Please assess the completion status of the following clinical trial:

Trial Title: Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* Males and females~* Indication for laparoscopic nephrectomy~Exclusion Criteria:~* Blood donation within the last month~* Lack of wish to participate~* eGFR\< 15ml/min~* Pregnancy or breast feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Voluven (Hydroxyethyl starch 130/0,4) (Type: ACTIVE_COMPARATOR): Patients undergoing laparoscopic nephrectomy will receive either fluid therapy with active comparator (Voluven) or placebo (Sodium Chloride)
- Sodium Chloride 9mg/ml (Type: PLACEBO_COMPARATOR): Patients undergoing laparoscopic nephrectomy will receive either fluid therapy with active comparator (Voluven) or placebo (Sodium Chloride)

Based on this trial design, predict the completion outcome and termination type (if applicable).